Primary Research · 2007
Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes
Wade AG, Ford I, Crawford G, et al. · Current Medical Research and Opinion, 2007
Key finding
3-week RCT in older insomnia patients (n=354) found prolonged-release melatonin 2mg improved sleep quality and morning alertness, supporting lower doses (1–3mg) over the often-oversold 5–10mg.
About the supplement
Melatonin
Dose · mechanism · evidence grade · safety →
Read the paper
Open on PubMedhttps://pubmed.ncbi.nlm.nih.gov/17959198/
About this page
Formulate maintains a registry of clinical studies cited across its guides and evidence grades. This page links the study metadata to the content that cites it — one canonical entry per landmark study.
The full citation chain is public so readers can verify claims without hunting through individual guide pages. Browse all cited studies →
Note: Study summaries on this page are editorial interpretations of the research. Always consult the primary source before drawing clinical conclusions.